| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5G3 OR5L1 CYSLTR1 OR52E8 GPR87 ADGRF5 CCR7 OR8J1 OR5L2 OR2B6 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 1.17e-17 | 884 | 59 | 24 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5G3 PTPRR OR5L1 CYSLTR1 OR52E8 GPR87 ADGRF5 CCR7 OR8J1 OR5L2 OR2B6 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 1.54e-14 | 1353 | 59 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.27e-07 | 133 | 59 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.80e-07 | 140 | 59 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | odorant binding | 2.01e-06 | 127 | 59 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 4.52e-06 | 431 | 59 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 4.16e-05 | 23 | 59 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 4.75e-05 | 24 | 59 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 5.13e-05 | 4 | 59 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 6.07e-05 | 26 | 59 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 6.07e-05 | 26 | 59 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.26e-04 | 33 | 59 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.77e-04 | 37 | 59 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.79e-04 | 7 | 59 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 3.05e-04 | 9 | 59 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 3.05e-04 | 9 | 59 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.94e-04 | 459 | 59 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 4.64e-04 | 11 | 59 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.17e-04 | 53 | 59 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | channel activity | 8.72e-04 | 525 | 59 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 8.82e-04 | 526 | 59 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.21e-03 | 793 | 59 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | KCNMB2 SLC7A8 SLC9B1 ANO9 PSEN1 ABCB6 KCNK13 GRM7 LRRC8D OPRM1 | 2.22e-03 | 1180 | 59 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.45e-03 | 465 | 59 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | G-protein beta-subunit binding | 2.46e-03 | 25 | 59 | 2 | GO:0031681 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.87e-03 | 27 | 59 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 2.97e-03 | 97 | 59 | 3 | GO:0004896 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.04e-03 | 334 | 59 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.40e-03 | 343 | 59 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | transporter activity | KCNMB2 SLC7A8 SLC9B1 ANO9 PSEN1 ABCB6 KCNK13 GRM7 LRRC8D OPRM1 | 4.20e-03 | 1289 | 59 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | calcium channel activity | 6.58e-03 | 129 | 59 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 6.79e-03 | 758 | 59 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 7.17e-03 | 43 | 59 | 2 | GO:0001965 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 8.17e-03 | 46 | 59 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 8.87e-03 | 48 | 59 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 9.60e-03 | 50 | 59 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 9.97e-03 | 51 | 59 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.01e-02 | 151 | 59 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.03e-02 | 627 | 59 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.03e-02 | 152 | 59 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.12e-02 | 157 | 59 | 3 | GO:0019955 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5G3 OR5L1 CYSLTR1 OR52E8 GPR87 ADGRF5 CCR7 OR8J1 OR5L2 OR2B6 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 1.50e-13 | 1395 | 59 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception | OR5P2 CCR2 OR52B4 OR8J3 OR5G3 OR5L1 OR52E8 PTGES OR8J1 MARVELD2 OR5L2 OR2B6 GRM7 GRM8 OPRK1 OPRM1 | 3.36e-08 | 1072 | 59 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5P2 KCNMB2 OR52B4 OR8J3 OR5G3 OR5L1 OR52E8 OR8J1 OR5L2 OR2B6 | 2.11e-06 | 524 | 59 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 3.43e-06 | 224 | 59 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 3.55e-06 | 432 | 59 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5P2 OR52B4 OR8J3 OR5G3 OR5L1 OR52E8 OR8J1 OR5L2 OR2B6 GRM8 | 5.36e-06 | 582 | 59 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5P2 KCNMB2 OR52B4 OR8J3 OR5G3 OR5L1 OR52E8 OR8J1 OR5L2 OR2B6 GRM8 | 5.42e-06 | 722 | 59 | 11 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of smell | 6.44e-06 | 465 | 59 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 9.03e-06 | 485 | 59 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 1.25e-05 | 105 | 59 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.34e-05 | 547 | 59 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting opioid receptor signaling pathway | 2.41e-05 | 3 | 59 | 2 | GO:0031635 | |
| GeneOntologyBiologicalProcess | regulation of eosinophil degranulation | 2.41e-05 | 3 | 59 | 2 | GO:0043309 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 2.80e-05 | 124 | 59 | 5 | GO:0007218 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | KCNMB2 CCR2 SLC9B1 ANO9 PSEN1 ABCB6 KCNK13 CCR7 LRRC8D ADCYAP1R1 OPRK1 OPRM1 | 6.20e-05 | 1115 | 59 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 6.51e-05 | 148 | 59 | 5 | GO:0002286 | |
| GeneOntologyBiologicalProcess | mature conventional dendritic cell differentiation | 8.00e-05 | 5 | 59 | 2 | GO:0097029 | |
| GeneOntologyBiologicalProcess | positive regulation of thymocyte migration | 8.00e-05 | 5 | 59 | 2 | GO:2000412 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.08e-04 | 86 | 59 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | KCNMB2 CCR2 SLC9B1 ANO9 PSEN1 CYSLTR1 ABCB6 KCNK13 CCR7 LRRC8D ADCYAP1R1 OPRK1 OPRM1 | 1.09e-04 | 1374 | 59 | 13 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of thymocyte migration | 1.20e-04 | 6 | 59 | 2 | GO:2000410 | |
| GeneOntologyBiologicalProcess | negative regulation of luteinizing hormone secretion | 1.20e-04 | 6 | 59 | 2 | GO:0033685 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.40e-04 | 92 | 59 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.64e-04 | 286 | 59 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | eosinophil activation involved in immune response | 2.86e-04 | 9 | 59 | 2 | GO:0002278 | |
| GeneOntologyBiologicalProcess | thymocyte migration | 2.86e-04 | 9 | 59 | 2 | GO:0072679 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 2.86e-04 | 9 | 59 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | eosinophil degranulation | 2.86e-04 | 9 | 59 | 2 | GO:0043308 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 1 cell differentiation | 2.86e-04 | 9 | 59 | 2 | GO:0045627 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 3.00e-04 | 320 | 59 | 6 | GO:0002274 | |
| GeneOntologyBiologicalProcess | eosinophil activation | 3.57e-04 | 10 | 59 | 2 | GO:0043307 | |
| GeneOntologyBiologicalProcess | eosinophil mediated immunity | 3.57e-04 | 10 | 59 | 2 | GO:0002447 | |
| GeneOntologyBiologicalProcess | regulation of luteinizing hormone secretion | 3.57e-04 | 10 | 59 | 2 | GO:0033684 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 3.64e-04 | 214 | 59 | 5 | GO:1903531 | |
| GeneOntologyBiologicalProcess | negative regulation of gonadotropin secretion | 4.35e-04 | 11 | 59 | 2 | GO:0032277 | |
| GeneOntologyBiologicalProcess | metal ion transport | KCNMB2 SLC9B1 PSEN1 CYSLTR1 ABCB6 KCNK13 CCR7 ADCYAP1R1 OPRK1 OPRM1 | 4.95e-04 | 1000 | 59 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 4.97e-04 | 54 | 59 | 3 | GO:0097028 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 5.55e-04 | 132 | 59 | 4 | GO:0035249 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | KCNMB2 SLC9B1 ANO9 PSEN1 ABCB6 KCNK13 CCR7 ADCYAP1R1 OPRK1 OPRM1 | 5.64e-04 | 1017 | 59 | 10 | GO:0098660 |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | 5.69e-04 | 361 | 59 | 6 | GO:0002366 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 6.03e-04 | 365 | 59 | 6 | GO:0002263 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 6.03e-04 | 239 | 59 | 5 | GO:0051048 | |
| GeneOntologyBiologicalProcess | granulocyte activation | 6.13e-04 | 58 | 59 | 3 | GO:0036230 | |
| GeneOntologyBiologicalProcess | positive regulation of pseudopodium assembly | 6.15e-04 | 13 | 59 | 2 | GO:0031274 | |
| GeneOntologyBiologicalProcess | regulation of pseudopodium assembly | 6.15e-04 | 13 | 59 | 2 | GO:0031272 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 6.15e-04 | 13 | 59 | 2 | GO:0038003 | |
| GeneOntologyBiologicalProcess | inflammatory response | 6.86e-04 | 1043 | 59 | 10 | GO:0006954 | |
| GeneOntologyBiologicalProcess | regulation of endocrine process | 7.11e-04 | 61 | 59 | 3 | GO:0044060 | |
| GeneOntologyBiologicalProcess | luteinizing hormone secretion | 7.16e-04 | 14 | 59 | 2 | GO:0032275 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 1 cell differentiation | 7.16e-04 | 14 | 59 | 2 | GO:0045625 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 7.51e-04 | 251 | 59 | 5 | GO:0002285 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 9.35e-04 | 67 | 59 | 3 | GO:0099171 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell chemotaxis | 9.41e-04 | 16 | 59 | 2 | GO:0010820 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 9.41e-04 | 16 | 59 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of gonadotropin secretion | 9.41e-04 | 16 | 59 | 2 | GO:0032276 | |
| GeneOntologyBiologicalProcess | pseudopodium assembly | 1.06e-03 | 17 | 59 | 2 | GO:0031269 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.15e-03 | 922 | 59 | 9 | GO:0098662 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 1.19e-03 | 18 | 59 | 2 | GO:0007194 | |
| GeneOntologyBiologicalProcess | regulation of NMDA receptor activity | 1.19e-03 | 18 | 59 | 2 | GO:2000310 | |
| GeneOntologyBiologicalProcess | pseudopodium organization | 1.33e-03 | 19 | 59 | 2 | GO:0031268 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 1.33e-03 | 19 | 59 | 2 | GO:0031280 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.34e-03 | 942 | 59 | 9 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.48e-03 | 20 | 59 | 2 | GO:0010819 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage activation | 1.48e-03 | 20 | 59 | 2 | GO:0043031 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KCNMB2 SLC9B1 PSEN1 CYSLTR1 ABCB6 KCNK13 CCR7 ADCYAP1R1 OPRK1 OPRM1 | 1.51e-03 | 1157 | 59 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | T cell migration | 1.62e-03 | 81 | 59 | 3 | GO:0072678 | |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 1.79e-03 | 22 | 59 | 2 | GO:0051350 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte chemotaxis | 1.79e-03 | 22 | 59 | 2 | GO:0140131 | |
| GeneOntologyBiologicalProcess | gonadotropin secretion | 1.79e-03 | 22 | 59 | 2 | GO:0032274 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.28e-04 | 277 | 59 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.21e-04 | 583 | 59 | 8 | GO:0097060 | |
| MousePheno | abnormal hypersensitivity reaction | 2.40e-05 | 174 | 47 | 6 | MP:0002148 | |
| MousePheno | abnormal associative learning | 4.37e-05 | 393 | 47 | 8 | MP:0002062 | |
| MousePheno | abnormal intromission | 1.10e-04 | 5 | 47 | 2 | MP:0031628 | |
| MousePheno | impaired behavioral response to anesthetic | 1.10e-04 | 5 | 47 | 2 | MP:0009778 | |
| MousePheno | abnormal type I hypersensitivity reaction | 1.78e-04 | 84 | 47 | 4 | MP:0002531 | |
| MousePheno | decreased capillary density | 2.30e-04 | 7 | 47 | 2 | MP:0020329 | |
| MousePheno | abnormal touch/ nociception | 2.40e-04 | 376 | 47 | 7 | MP:0001968 | |
| MousePheno | abnormal pain threshold | 2.55e-04 | 267 | 47 | 6 | MP:0001970 | |
| MousePheno | abnormal bone marrow cell physiology | 3.73e-04 | 42 | 47 | 3 | MP:0009278 | |
| MousePheno | abnormal capillary density | 3.92e-04 | 9 | 47 | 2 | MP:0020328 | |
| MousePheno | decreased CD11b-high dendritic cell number | 3.92e-04 | 9 | 47 | 2 | MP:0013649 | |
| MousePheno | decreased susceptibility to injury | 4.67e-04 | 194 | 47 | 5 | MP:0005166 | |
| MousePheno | decreased inflammatory response | 4.76e-04 | 300 | 47 | 6 | MP:0001876 | |
| MousePheno | impaired behavioral response to morphine | 4.89e-04 | 10 | 47 | 2 | MP:0009757 | |
| Domain | GPCR_Rhodpsn_7TM | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5L1 CYSLTR1 OR52E8 GPR87 CCR7 OR8J1 OR5L2 OR2B6 F2RL1 OPRK1 OPRM1 | 9.84e-14 | 670 | 59 | 19 | IPR017452 |
| Domain | 7tm_1 | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5L1 CYSLTR1 OR52E8 GPR87 CCR7 OR8J1 OR5L2 OR2B6 F2RL1 OPRK1 OPRM1 | 1.18e-13 | 677 | 59 | 19 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5L1 CYSLTR1 OR52E8 GPR87 CCR7 OR8J1 OR5L2 OR2B6 F2RL1 OPRK1 OPRM1 | 1.46e-13 | 685 | 59 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5L1 CYSLTR1 OR52E8 GPR87 CCR7 OR8J1 OR5L2 OR2B6 F2RL1 OPRK1 OPRM1 | 1.71e-13 | 691 | 59 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5P2 CCR2 PROKR1 OR52B4 OR8J3 GPR15 PROKR2 CXCR6 OR5L1 CYSLTR1 OR52E8 GPR87 CCR7 OR8J1 OR5L2 OR2B6 F2RL1 OPRK1 OPRM1 | 1.75e-13 | 692 | 59 | 19 | IPR000276 |
| Domain | Chemokine_rcpt | 1.63e-05 | 16 | 59 | 3 | IPR000355 | |
| Domain | Olfact_rcpt | 3.11e-05 | 393 | 59 | 8 | IPR000725 | |
| Domain | Opioid_rcpt | 5.86e-05 | 4 | 59 | 2 | IPR001418 | |
| Domain | GPCR_3_mtglu_rcpt | 2.71e-04 | 8 | 59 | 2 | IPR000162 | |
| Domain | NPY_rcpt | 3.48e-04 | 9 | 59 | 2 | IPR000611 | |
| Domain | NCD3G | 7.48e-04 | 13 | 59 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 7.48e-04 | 13 | 59 | 2 | IPR011500 | |
| Domain | GPCR_3_CS | 8.71e-04 | 14 | 59 | 2 | IPR017979 | |
| Domain | GPCR_3 | 1.98e-03 | 21 | 59 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.18e-03 | 22 | 59 | 2 | PS50259 | |
| Domain | 7tm_3 | 2.18e-03 | 22 | 59 | 2 | PF00003 | |
| Domain | GPCR_3_C | 2.18e-03 | 22 | 59 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.18e-03 | 22 | 59 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.18e-03 | 22 | 59 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.18e-03 | 22 | 59 | 2 | PS00979 | |
| Domain | GPCR_2_secretin-like_CS | 5.16e-03 | 34 | 59 | 2 | IPR017983 | |
| Domain | 7TM_GPCR_Srsx | 5.35e-03 | 112 | 59 | 3 | SM01381 | |
| Domain | ANF_receptor | 6.09e-03 | 37 | 59 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 6.09e-03 | 37 | 59 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 6.74e-03 | 39 | 59 | 2 | IPR028082 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 7.08e-03 | 40 | 59 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 7.08e-03 | 40 | 59 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 7.08e-03 | 40 | 59 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.09e-02 | 50 | 59 | 2 | PS00650 | |
| Domain | 7tm_2 | 1.09e-02 | 50 | 59 | 2 | PF00002 | |
| Pathway | WP_GPCRS_NONODORANT | CCR2 PROKR1 GPR15 PROKR2 CXCR6 CYSLTR1 CCR7 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 4.11e-12 | 266 | 49 | 13 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CCR2 PROKR1 PROKR2 CXCR6 CYSLTR1 CCR7 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 4.18e-08 | 463 | 49 | 12 | M507 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | PROKR1 PROKR2 CXCR6 CYSLTR1 CCR7 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 1.92e-07 | 430 | 49 | 11 | MM15160 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.32e-07 | 260 | 49 | 9 | M39397 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 3.48e-07 | 197 | 49 | 8 | M12289 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CCR2 PROKR1 GPR15 PROKR2 CXCR6 CYSLTR1 CCR7 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 5.16e-07 | 702 | 49 | 13 | M746 |
| Pathway | WP_GPCRS_OTHER | 9.41e-07 | 96 | 49 | 6 | MM15939 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PROKR1 GPR15 PROKR2 CXCR6 CYSLTR1 CCR7 GRM7 F2RL1 GRM8 ADCYAP1R1 OPRK1 OPRM1 | 1.50e-06 | 646 | 49 | 12 | MM14962 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.70e-06 | 330 | 49 | 9 | M18334 | |
| Pathway | WP_GPCRS_PEPTIDE | 4.20e-06 | 70 | 49 | 5 | MM15959 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 4.89e-06 | 197 | 49 | 7 | MM14970 | |
| Pathway | WP_PEPTIDE_GPCRS | 5.92e-06 | 75 | 49 | 5 | M39696 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.73e-05 | 333 | 49 | 8 | MM14963 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.96e-05 | 272 | 49 | 7 | M13380 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.25e-05 | 186 | 49 | 6 | MM15994 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 5.24e-05 | 389 | 49 | 8 | M14091 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 8.53e-05 | 417 | 49 | 8 | M4072 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 9.79e-05 | 314 | 49 | 7 | M600 | |
| Pathway | WP_GPCRS_OTHER | 3.00e-04 | 93 | 49 | 4 | M39629 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47641 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.70e-04 | 289 | 49 | 6 | MM15057 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 1.01e-03 | 57 | 49 | 3 | M625 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.21e-03 | 15 | 49 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.21e-03 | 15 | 49 | 2 | MM15845 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.44e-03 | 636 | 49 | 8 | M41834 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 1.75e-03 | 18 | 49 | 2 | M27901 | |
| Pathway | WP_GPCRS_ODORANT | 2.12e-03 | 157 | 49 | 4 | MM15872 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 2.16e-03 | 20 | 49 | 2 | MM1529 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 7.00e-09 | 340 | 60 | 9 | 11875048 | |
| Pubmed | 7.00e-09 | 340 | 60 | 9 | 11802173 | ||
| Pubmed | 7.55e-09 | 343 | 60 | 9 | 32295537 | ||
| Pubmed | 8.14e-09 | 346 | 60 | 9 | 14611657 | ||
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 22086059 | ||
| Pubmed | Use of alternate coreceptors on primary cells by two HIV-1 isolates. | 1.70e-07 | 7 | 60 | 3 | 15992849 | |
| Pubmed | 2.99e-07 | 81 | 60 | 5 | 22723691 | ||
| Pubmed | 3.65e-07 | 541 | 60 | 9 | 14983052 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 12070001 | ||
| Pubmed | 6.79e-07 | 179 | 60 | 6 | 18577758 | ||
| Pubmed | 1.30e-06 | 200 | 60 | 6 | 18240029 | ||
| Pubmed | κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. | 2.93e-06 | 2 | 60 | 2 | 31940240 | |
| Pubmed | Differential involvement of the mu and kappa opioid receptors in spatial learning. | 2.93e-06 | 2 | 60 | 2 | 12884965 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28512665 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16901473 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 38658802 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23220400 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11886876 | ||
| Pubmed | Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. | 2.93e-06 | 2 | 60 | 2 | 16954126 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11912074 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26655190 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17185983 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27143420 | ||
| Pubmed | Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. | 2.93e-06 | 2 | 60 | 2 | 24651466 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26984842 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16530171 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27838450 | ||
| Pubmed | Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology. | 2.93e-06 | 2 | 60 | 2 | 23664812 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22138325 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22132188 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23687280 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27958613 | ||
| Pubmed | Ligand directed signaling differences between rodent and human κ-opioid receptors. | 2.93e-06 | 2 | 60 | 2 | 23086943 | |
| Pubmed | Expression cloning of new receptors used by simian and human immunodeficiency viruses. | 2.93e-06 | 2 | 60 | 2 | 9230441 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22262658 | ||
| Pubmed | 3.91e-06 | 18 | 60 | 3 | 23913046 | ||
| Pubmed | 6.35e-06 | 21 | 60 | 3 | 22842622 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19032295 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15090050 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19667192 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 10082819 | ||
| Pubmed | Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. | 8.77e-06 | 3 | 60 | 2 | 18338799 | |
| Pubmed | Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | 8.77e-06 | 3 | 60 | 2 | 18537939 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23220294 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 12603260 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17676326 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 26692286 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17374034 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17531315 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 30365572 | ||
| Pubmed | Quantitative trait loci influencing morphine antinociception in four mapping populations. | 8.77e-06 | 3 | 60 | 2 | 11420618 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11504820 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15178356 | ||
| Pubmed | Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. | 8.77e-06 | 3 | 60 | 2 | 12431223 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9572309 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 28049031 | ||
| Pubmed | Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. | 8.77e-06 | 3 | 60 | 2 | 22138749 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 26730729 | ||
| Pubmed | Formalin-induced pain is reduced in sigma(1) receptor knockout mice. | 8.77e-06 | 3 | 60 | 2 | 15777781 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 25614627 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 33068816 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15650194 | ||
| Pubmed | Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms. | 8.77e-06 | 3 | 60 | 2 | 26946441 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 31806881 | ||
| Pubmed | Nociception increases during opioid infusion in opioid receptor triple knock-out mice. | 8.77e-06 | 3 | 60 | 2 | 17544222 | |
| Pubmed | Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | 8.77e-06 | 3 | 60 | 2 | 14745298 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 27653688 | ||
| Pubmed | Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. | 8.77e-06 | 3 | 60 | 2 | 20023120 | |
| Pubmed | Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 8.77e-06 | 3 | 60 | 2 | 8114680 | |
| Pubmed | Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. | 8.77e-06 | 3 | 60 | 2 | 22752269 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11032994 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 25855262 | ||
| Pubmed | Opioid receptors: from binding sites to visible molecules in vivo. | 8.77e-06 | 3 | 60 | 2 | 18718480 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 20847187 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24874714 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 10985245 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9473604 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24184057 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 33811988 | ||
| Pubmed | Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. | 8.77e-06 | 3 | 60 | 2 | 11826143 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 18213616 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 33555255 | ||
| Pubmed | Enhanced humoral response in kappa-opioid receptor knockout mice. | 8.77e-06 | 3 | 60 | 2 | 12507774 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 14975676 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 25064403 | ||
| Pubmed | Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. | 8.77e-06 | 3 | 60 | 2 | 11069979 | |
| Pubmed | 1.73e-05 | 29 | 60 | 3 | 34678150 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 15126578 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 12604792 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 17997230 | ||
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 1.75e-05 | 4 | 60 | 2 | 8941707 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 28729715 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 31883821 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 12413885 | ||
| Pubmed | Migratory properties of pulmonary dendritic cells are determined by their developmental lineage. | 1.75e-05 | 4 | 60 | 2 | 23168837 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 10741397 | ||
| Pubmed | Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. | 1.75e-05 | 4 | 60 | 2 | 9502813 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 23352232 | ||
| Pubmed | The SALM/Lrfn family of leucine-rich repeat-containing cell adhesion molecules. | 1.75e-05 | 4 | 60 | 2 | 21736948 | |
| Pubmed | Prokineticins in central and peripheral control of human reproduction. | 1.75e-05 | 4 | 60 | 2 | 26574895 | |
| Interaction | GPRASP1 interactions | 2.29e-05 | 67 | 50 | 4 | int:GPRASP1 | |
| Interaction | AUP1 interactions | 2.38e-05 | 234 | 50 | 6 | int:AUP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 9.06e-05 | 345 | 60 | 5 | chr11q12 | |
| Cytoband | 3p21.31 | 3.14e-04 | 100 | 60 | 3 | 3p21.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 7.93e-04 | 316 | 60 | 4 | chr3p21 | |
| Cytoband | 11q12.1 | 1.25e-03 | 161 | 60 | 3 | 11q12.1 | |
| Cytoband | 11q11 | 1.75e-03 | 47 | 60 | 2 | 11q11 | |
| Cytoband | 11p15.4 | 2.32e-03 | 200 | 60 | 3 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 6.39e-03 | 564 | 60 | 4 | chr11p15 | |
| GeneFamily | Prokineticin receptors | 8.43e-06 | 2 | 53 | 2 | 216 | |
| GeneFamily | Opioid receptors | 5.04e-05 | 4 | 53 | 2 | 245 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.33e-04 | 8 | 53 | 2 | 281 | |
| GeneFamily | Olfactory receptors, family 5 | 3.23e-04 | 112 | 53 | 4 | 152 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 3.74e-04 | 10 | 53 | 2 | 1091 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.83e-03 | 394 | 53 | 5 | 471 | |
| GeneFamily | Olfactory receptors, family 8 | 9.08e-03 | 49 | 53 | 2 | 155 | |
| GeneFamily | Olfactory receptors, family 52 | 9.08e-03 | 49 | 53 | 2 | 165 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.17e-02 | 161 | 53 | 3 | 593 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.20e-02 | 78 | 53 | 2 | 262 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Cilia-bearing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.85e-07 | 199 | 60 | 6 | 2d8ab4aee300c7c4baf662940ce855da2b6d2cae | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-06 | 170 | 60 | 5 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-06 | 173 | 60 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-06 | 174 | 60 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | CV-Severe-5|Severe / Virus stimulation, Condition and Cluster | 5.91e-06 | 191 | 60 | 5 | d04f93fc85c882260ca4d5b4768504fbf8a47984 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.06e-06 | 192 | 60 | 5 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.22e-06 | 193 | 60 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | CD8+_Memory_T_cell-CV-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.38e-06 | 194 | 60 | 5 | 5d644fe6da99b023eee100882ee7b71af4f3814a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.38e-06 | 194 | 60 | 5 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.04e-06 | 198 | 60 | 5 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.31e-06 | 95 | 60 | 4 | 56350551af6a1ae15652d596002124d8f7885d4f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-05 | 121 | 60 | 4 | 056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 128 | 60 | 4 | 376102331d79010c1b2ce26e6ab0134c7b8a4ec3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.95e-05 | 131 | 60 | 4 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.13e-05 | 133 | 60 | 4 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.93e-05 | 141 | 60 | 4 | b2857b73fd754b879b922c7720b5ac3024976822 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 153 | 60 | 4 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 153 | 60 | 4 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 153 | 60 | 4 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 153 | 60 | 4 | 3724dd498b982be693ddff9cea7671863acf3ff8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 153 | 60 | 4 | d810fc5aff28449ce79b4148558b260878a2c696 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.59e-05 | 161 | 60 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 162 | 60 | 4 | 15d5d31a75e26bcd41919a00300c68e9f00f0002 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.95e-05 | 59 | 60 | 3 | d49a63218a045f3d032d135aee234a3269222abd | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.95e-05 | 59 | 60 | 3 | 2d77ae08fa9836bbae158a0e466806a5f9236b5e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 165 | 60 | 4 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 165 | 60 | 4 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.42e-05 | 166 | 60 | 4 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.42e-05 | 166 | 60 | 4 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.42e-05 | 166 | 60 | 4 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 168 | 60 | 4 | 749eccebe4ee066f827d2a3980512f195f23ac27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-05 | 169 | 60 | 4 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.13e-05 | 170 | 60 | 4 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.32e-05 | 171 | 60 | 4 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.51e-05 | 172 | 60 | 4 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | droplet-Limb_Muscle-nan-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 172 | 60 | 4 | 770e4c5467ef2eaddf883723fb0aa1226973b000 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 172 | 60 | 4 | adf016e5856bc85e7bed58aee09ade483b9dcb00 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.70e-05 | 173 | 60 | 4 | 5aa4d45a01d2d09eff8b4deb32bd91ab2471210a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 173 | 60 | 4 | 62ba49c1c16760a8c6cde0cc44e068f94386946a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.70e-05 | 173 | 60 | 4 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-05 | 174 | 60 | 4 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.90e-05 | 174 | 60 | 4 | 73e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.90e-05 | 174 | 60 | 4 | 7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | 52402ff6299210c46fd9dee3cef203c0eda7a98a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | 6561794ae3b14b5279b249eb5e93b80ef15ed82c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.51e-05 | 177 | 60 | 4 | c80893e5cf5688ee9f5afc8f11b3890f296c9e1f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.72e-05 | 178 | 60 | 4 | 5101a45595cd8d702f911afadf1eb0ee10bdcefc | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 9.72e-05 | 178 | 60 | 4 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.93e-05 | 179 | 60 | 4 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 180 | 60 | 4 | 5fdd10ffdf49f0e818f865ca095a3882b35c640e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 180 | 60 | 4 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 180 | 60 | 4 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 180 | 60 | 4 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 180 | 60 | 4 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 181 | 60 | 4 | c1203787cc3f968147fabdd3c646a04be96f6552 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 181 | 60 | 4 | f7258af89f4cc89446ff6754bdaa769320af95d6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 183 | 60 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 1.10e-04 | 184 | 60 | 4 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 186 | 60 | 4 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tfr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 70 | 60 | 3 | 125f8e8fcd14420dff5b18f2270516d5baafd38e | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.20e-04 | 188 | 60 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.20e-04 | 188 | 60 | 4 | c19c89756f2f999e0814f08a89818ef156f6fc69 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 189 | 60 | 4 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 1.27e-04 | 191 | 60 | 4 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 60 | 4 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | wk_08-11-Epithelial-PNS-SST+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 60 | 4 | df2bef74a54f4c23c99bd3b93225fd36bcd90723 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.27e-04 | 191 | 60 | 4 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 60 | 4 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | CV-Mild-5|Mild / Virus stimulation, Condition and Cluster | 1.33e-04 | 193 | 60 | 4 | 2053f0f8083b3174e1b6f76d2d7089f59982565d | |
| ToppCell | CV-Severe-5|CV / Virus stimulation, Condition and Cluster | 1.33e-04 | 193 | 60 | 4 | d87fcd4553b6198c3128685b73ffd1b1ae88fbb5 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 193 | 60 | 4 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 193 | 60 | 4 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 193 | 60 | 4 | bbe642f8b66ba9d028709deaf847f2f7e73be04f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 194 | 60 | 4 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 194 | 60 | 4 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 194 | 60 | 4 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 194 | 60 | 4 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 194 | 60 | 4 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.38e-04 | 195 | 60 | 4 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | CV-Moderate-5|CV / Virus stimulation, Condition and Cluster | 1.38e-04 | 195 | 60 | 4 | 7a0bb304c659dd108b75d0c5d19eca5e63cf856d | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.38e-04 | 195 | 60 | 4 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.41e-04 | 196 | 60 | 4 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 196 | 60 | 4 | d5f9168001e60bafec17fe6c702e68f5528edc20 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.41e-04 | 196 | 60 | 4 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.44e-04 | 197 | 60 | 4 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.49e-04 | 199 | 60 | 4 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 199 | 60 | 4 | f8846446ebbc4948cdc69640782db1358bbdc486 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.49e-04 | 199 | 60 | 4 | fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 199 | 60 | 4 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 199 | 60 | 4 | 3e35ee426ef06f9af568c37349b62dd1ee9b97ea | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 199 | 60 | 4 | e655cb92fe674b07096bb697d6befe0314ccbc5f | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | f6af5ef02625aaae21e885e1ebd195e34731e53a | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | 53f61e28c3ad6399f63c54e06120ecb5ebbf90d9 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | c1f243ae929f7791e040437470033abf749b44cc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 200 | 60 | 4 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 200 | 60 | 4 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.52e-04 | 200 | 60 | 4 | 631550dc34bcb605ab726645f4024d7828bb7975 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 89 | 60 | 3 | b66575739cb5b89234bbb8a3ea2f244e0bd19cff | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 89 | 60 | 3 | 26f01e8530b313dd5e95ea6c20fa362e34b9ed24 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.73e-04 | 104 | 60 | 3 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| Computational | GPCR signaling pathways (immune and neuro). | 4.44e-06 | 90 | 30 | 5 | MODULE_375 | |
| Computational | Genes in the cancer module 289. | 2.13e-05 | 124 | 30 | 5 | MODULE_289 | |
| Computational | Genes in the cancer module 134. | 7.57e-05 | 30 | 30 | 3 | MODULE_134 | |
| Computational | Genes in the cancer module 288. | 1.43e-04 | 37 | 30 | 3 | MODULE_288 | |
| Computational | Genes in the cancer module 146. | 1.73e-04 | 102 | 30 | 4 | MODULE_146 | |
| Computational | Genes in the cancer module 27. | 3.77e-04 | 355 | 30 | 6 | MODULE_27 | |
| Computational | Neighborhood of MAP2K7 | 1.51e-03 | 181 | 30 | 4 | MORF_MAP2K7 | |
| Computational | Neighborhood of CTSB | 1.71e-03 | 187 | 30 | 4 | MORF_CTSB | |
| Drug | 3-dadh-ol | 6.60e-06 | 2 | 59 | 2 | CID000128663 | |
| Drug | Dezocine | 6.60e-06 | 2 | 59 | 2 | DB01209 | |
| Drug | GUM1 compound | 6.60e-06 | 2 | 59 | 2 | ctd:C000611307 | |
| Drug | P 7521 | 6.60e-06 | 2 | 59 | 2 | CID000146384 | |
| Drug | N-propargyl | 6.60e-06 | 2 | 59 | 2 | ctd:C440369 | |
| Drug | N-(3-iodoprop-(2)-enyl) | 6.60e-06 | 2 | 59 | 2 | ctd:C440388 | |
| Drug | methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate | 6.60e-06 | 2 | 59 | 2 | ctd:C533093 | |
| Drug | Cyclazocine | 6.60e-06 | 2 | 59 | 2 | ctd:D003496 | |
| Drug | paynantheine | 6.60e-06 | 2 | 59 | 2 | ctd:C580857 | |
| Drug | dihydroheroin | 6.60e-06 | 2 | 59 | 2 | CID005359460 | |
| Drug | AC1L9NAZ | 1.23e-05 | 198 | 59 | 6 | CID000449606 | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.23e-05 | 198 | 59 | 6 | 4352_UP | |
| Drug | Pentazocine | 1.98e-05 | 3 | 59 | 2 | ctd:D010423 | |
| Drug | cyclorphan | 1.98e-05 | 3 | 59 | 2 | ctd:C084603 | |
| Drug | TRK 820 | 1.98e-05 | 3 | 59 | 2 | ctd:C111212 | |
| Drug | Oxycodone | 1.98e-05 | 3 | 59 | 2 | DB00497 | |
| Drug | Hydromorphone | 1.98e-05 | 3 | 59 | 2 | DB00327 | |
| Drug | Codeine | 1.98e-05 | 3 | 59 | 2 | DB00318 | |
| Drug | Lactoferroxin C | 1.98e-05 | 3 | 59 | 2 | CID000192714 | |
| Drug | Lactoferroxin B | 1.98e-05 | 3 | 59 | 2 | CID000192715 | |
| Drug | Lactoferroxin A | 1.98e-05 | 3 | 59 | 2 | CID000192716 | |
| Drug | Carfentanil | 1.98e-05 | 3 | 59 | 2 | DB01535 | |
| Drug | Morphine | 1.98e-05 | 3 | 59 | 2 | DB00295 | |
| Drug | Hydrocodone | 1.98e-05 | 3 | 59 | 2 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 1.98e-05 | 3 | 59 | 2 | DB01571 | |
| Drug | Alvimopan | 1.98e-05 | 3 | 59 | 2 | DB06274 | |
| Drug | dextrallorphan | 1.98e-05 | 3 | 59 | 2 | ctd:C044130 | |
| Drug | Heroin | 1.98e-05 | 3 | 59 | 2 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 1.98e-05 | 3 | 59 | 2 | DB01439 | |
| Drug | 14-phenylpropoxymetopon | 1.98e-05 | 3 | 59 | 2 | ctd:C478565 | |
| Drug | morphine-7,8-oxide | 1.98e-05 | 3 | 59 | 2 | CID005491901 | |
| Drug | Levorphanol | 1.98e-05 | 3 | 59 | 2 | ctd:D007981 | |
| Drug | Levallorphan | 1.98e-05 | 3 | 59 | 2 | ctd:D007977 | |
| Drug | Buprenorphine | 1.98e-05 | 3 | 59 | 2 | DB00921 | |
| Drug | Levorphanol | 1.98e-05 | 3 | 59 | 2 | DB00854 | |
| Drug | Remifentanil | 1.98e-05 | 3 | 59 | 2 | DB00899 | |
| Drug | Nalbuphine | 1.98e-05 | 3 | 59 | 2 | DB00844 | |
| Drug | Fentanyl | 1.98e-05 | 3 | 59 | 2 | DB00813 | |
| Drug | Sufentanil | 1.98e-05 | 3 | 59 | 2 | DB00708 | |
| Drug | Propoxyphene | 1.98e-05 | 3 | 59 | 2 | DB00647 | |
| Drug | Butorphanol | 1.98e-05 | 3 | 59 | 2 | DB00611 | |
| Drug | bromadoline | 1.98e-05 | 3 | 59 | 2 | CID000054753 | |
| Drug | Butorphanol | 1.98e-05 | 3 | 59 | 2 | ctd:D002077 | |
| Drug | Pentazocine | 1.98e-05 | 3 | 59 | 2 | DB00652 | |
| Drug | Nalbuphine | 3.95e-05 | 4 | 59 | 2 | ctd:D009266 | |
| Drug | Dynorphins | 3.95e-05 | 4 | 59 | 2 | ctd:D004399 | |
| Drug | AC1L5BQM | 3.95e-05 | 4 | 59 | 2 | CID000174892 | |
| Drug | Diprenorphine | 3.95e-05 | 4 | 59 | 2 | DB01548 | |
| Drug | 3B-b | 3.95e-05 | 4 | 59 | 2 | CID000533975 | |
| Drug | diphenoxylate | 3.95e-05 | 4 | 59 | 2 | CID000013505 | |
| Drug | Meperidine | 3.95e-05 | 4 | 59 | 2 | ctd:D008614 | |
| Drug | Methadyl Acetate | 3.95e-05 | 4 | 59 | 2 | ctd:D008692 | |
| Drug | 7-hydroxymitragynine | 3.95e-05 | 4 | 59 | 2 | ctd:C482678 | |
| Drug | NSC1953 | 3.95e-05 | 4 | 59 | 2 | CID000102946 | |
| Drug | Naltrexone | 3.95e-05 | 4 | 59 | 2 | DB00704 | |
| Drug | Dihydromorphine | 6.57e-05 | 5 | 59 | 2 | DB01565 | |
| Drug | Naloxone | 6.57e-05 | 5 | 59 | 2 | DB01183 | |
| Drug | nalorphine-epoxide | 6.57e-05 | 5 | 59 | 2 | CID003086440 | |
| Drug | oxymorphamine | 6.57e-05 | 5 | 59 | 2 | CID000134844 | |
| Drug | nalmefene | 6.57e-05 | 5 | 59 | 2 | ctd:C038981 | |
| Drug | Sc 39566 | 6.57e-05 | 5 | 59 | 2 | CID000130018 | |
| Drug | XeC compound | 6.72e-05 | 84 | 59 | 4 | CID000005701 | |
| Drug | Zymosan | 8.36e-05 | 172 | 59 | 5 | ctd:D015054 | |
| Drug | Pilocarpine | 9.42e-05 | 285 | 59 | 6 | ctd:D010862 | |
| Drug | Etorphine | 9.84e-05 | 6 | 59 | 2 | DB01497 | |
| Drug | AC1L2OET | 9.84e-05 | 6 | 59 | 2 | CID000125331 | |
| Drug | NSC612111 | 9.84e-05 | 6 | 59 | 2 | CID000163346 | |
| Drug | Loperamide | 9.84e-05 | 6 | 59 | 2 | DB00836 | |
| Drug | RX8008M | 9.84e-05 | 6 | 59 | 2 | CID000162443 | |
| Drug | phenylquinone | 1.11e-04 | 36 | 59 | 3 | CID000009688 | |
| Drug | tetradotoxin | 1.16e-04 | 428 | 59 | 7 | CID000020382 | |
| Drug | tert-butylamine | 1.21e-04 | 37 | 59 | 3 | CID000006385 | |
| Drug | AC1L1DXE | 1.23e-04 | 299 | 59 | 6 | CID000002548 | |
| Drug | baclofen | 1.37e-04 | 191 | 59 | 5 | CID000002284 | |
| Drug | Pcl-dpdpe | 1.37e-04 | 7 | 59 | 2 | CID000159564 | |
| Drug | Tyr-ala-phe-gly | 1.37e-04 | 7 | 59 | 2 | CID005487532 | |
| Drug | Dextropropoxyphene | 1.37e-04 | 7 | 59 | 2 | ctd:D011431 | |
| Drug | aminocyclohexanecarboxylic acid | 1.37e-04 | 7 | 59 | 2 | CID000171560 | |
| Drug | Enkephalin, D-Penicillamine (2,5)- | 1.37e-04 | 7 | 59 | 2 | ctd:D020881 | |
| Drug | MET-CAMO | 1.37e-04 | 7 | 59 | 2 | CID006450159 | |
| Drug | phenylmorphan | 1.37e-04 | 7 | 59 | 2 | CID000146306 | |
| Drug | AC1L9PCU | 1.37e-04 | 7 | 59 | 2 | CID000451042 | |
| Drug | N-cyclopropylmethylnorazidomorphine | 1.37e-04 | 7 | 59 | 2 | CID005489191 | |
| Drug | beta-naltrexamine | 1.37e-04 | 7 | 59 | 2 | CID005486948 | |
| Drug | Dextrorphan | 1.37e-04 | 7 | 59 | 2 | ctd:D003917 | |
| Drug | NDTMB | 1.37e-04 | 7 | 59 | 2 | CID000134748 | |
| Drug | 2-mercaptoacetate | 1.37e-04 | 7 | 59 | 2 | ctd:C017487 | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 59 | 5 | 6710_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 4623_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 3277_UP | |
| Drug | ICI 204448 | 1.83e-04 | 8 | 59 | 2 | CID000003683 | |
| Drug | cis-MCG-I | 1.83e-04 | 8 | 59 | 2 | CID003035584 | |
| Drug | U 69593 | 1.83e-04 | 8 | 59 | 2 | ctd:C045444 | |
| Drug | metazocine | 1.83e-04 | 8 | 59 | 2 | CID000062518 | |
| Drug | AC1L1B1Q | 1.83e-04 | 8 | 59 | 2 | CID000001246 | |
| Drug | DIPPA | 1.83e-04 | 8 | 59 | 2 | CID000127914 | |
| Drug | 14-methoxymetopon | 1.83e-04 | 8 | 59 | 2 | CID005486940 | |
| Drug | KT-89 | 1.83e-04 | 8 | 59 | 2 | CID005748450 | |
| Drug | binaltorphimine | 1.83e-04 | 8 | 59 | 2 | CID005484197 | |
| Drug | N-methyl nalorphine | 1.83e-04 | 8 | 59 | 2 | CID005748235 | |
| Disease | Pruritus | 9.83e-05 | 8 | 56 | 2 | C0033774 | |
| Disease | asthma (is_implicated_in) | 2.28e-04 | 157 | 56 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | response to anticonvulsant | 5.73e-04 | 85 | 56 | 3 | GO_0036277 | |
| Disease | Attention Deficit Disorder | 7.98e-04 | 22 | 56 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 7.98e-04 | 22 | 56 | 2 | C1321905 | |
| Disease | Anhedonia | 9.51e-04 | 24 | 56 | 2 | C0178417 | |
| Disease | Attention deficit hyperactivity disorder | 9.51e-04 | 24 | 56 | 2 | C1263846 | |
| Disease | osteonecrosis | 1.03e-03 | 25 | 56 | 2 | EFO_0004259 | |
| Disease | plasma clusterin measurement | 1.03e-03 | 25 | 56 | 2 | EFO_0007656 | |
| Disease | Drug habituation | 1.38e-03 | 115 | 56 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.38e-03 | 115 | 56 | 3 | C0236969 | |
| Disease | Drug abuse | 1.38e-03 | 115 | 56 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.38e-03 | 115 | 56 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.38e-03 | 115 | 56 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.38e-03 | 115 | 56 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.38e-03 | 115 | 56 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.38e-03 | 115 | 56 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.38e-03 | 115 | 56 | 3 | C4316881 | |
| Disease | Mental Depression | 1.39e-03 | 254 | 56 | 4 | C0011570 | |
| Disease | colorectal cancer, overall survival | 1.39e-03 | 29 | 56 | 2 | EFO_0000638, MONDO_0005575 | |
| Disease | Substance abuse problem | 1.41e-03 | 116 | 56 | 3 | C0740858 | |
| Disease | rhinitis (is_implicated_in) | 1.49e-03 | 30 | 56 | 2 | DOID:4483 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | 1.69e-03 | 268 | 56 | 4 | C0001973 | |
| Disease | Depressive disorder | 2.22e-03 | 289 | 56 | 4 | C0011581 | |
| Disease | body weight | 2.49e-03 | 1261 | 56 | 8 | EFO_0004338 | |
| Disease | personality trait | 2.51e-03 | 39 | 56 | 2 | EFO_0004365 | |
| Disease | rhinitis (is_marker_for) | 3.47e-03 | 46 | 56 | 2 | DOID:4483 (is_marker_for) | |
| Disease | congenital left-sided heart lesions | 3.77e-03 | 48 | 56 | 2 | EFO_0005938 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMIVCYSVIIKTLLH | 206 | O00574 | |
| CYIVISKRHITMLSI | 56 | Q9H5V8 | |
| LRITYMTDSCLEKLL | 66 | Q6PIY5 | |
| VLLLTCMSVDRYLAI | 121 | P49685 | |
| LLAMSFCYLVIIRTL | 236 | P32248 | |
| IVFLCMSLYLTLTIV | 416 | Q9NP58 | |
| SYLRSTVILVLTLLM | 326 | A1A5B4 | |
| KSMILHSITRCVYLL | 86 | Q5T9G4 | |
| ELLTLVSQKMCVVVY | 481 | Q9UHI5 | |
| VLVFIIILMIRYKVC | 541 | Q96NI6 | |
| TVCYGLMILRLKSVR | 251 | P35372 | |
| MLVNLCSIRKVISYR | 81 | P58173 | |
| MVKLTQYLSLLCERI | 216 | Q9Y691 | |
| ALIKKICVTVSLRSY | 141 | Q8NGK2 | |
| TVAVYSTCMLVVLLR | 116 | P56589 | |
| SLLMVVLVLSYKSIC | 6 | P01567 | |
| LERLITIIAYIMKSC | 146 | Q9HB14 | |
| TILCMARLKTVLKYV | 621 | Q9HCN3 | |
| VSTSRILVAVVKMCY | 61 | O00232 | |
| RYTKTLLLPVVMVIT | 491 | Q6NUT2 | |
| LYMVVVSRRLCLLLV | 131 | Q8NGG0 | |
| SILLMVTCTVYAIKT | 756 | O00222 | |
| RMYSITFTKVLSVCV | 151 | Q9BY21 | |
| LIITYTTLMILLSRI | 136 | Q9Y2A7 | |
| VTLTTAMVILCRFRK | 166 | P41586 | |
| SIFVIIVTCLMILYR | 236 | Q15256 | |
| AVCYIYILITILKMR | 211 | Q8WZ92 | |
| IKLIVTVLAMYLICF | 286 | P55085 | |
| LYMVVVSRRLCLLLV | 131 | Q8NGP2 | |
| CLRLITTLSDKYMLV | 526 | Q7L622 | |
| YKIACIVLLALLVIM | 21 | O14638 | |
| LQVEVMKVLLCITYT | 111 | Q5TH69 | |
| LIMVICYSGILKTLL | 216 | P41597 | |
| TMIVYLISALVCLKL | 351 | Q8N4S9 | |
| MLYERRILIICSKLS | 191 | Q8TEH3 | |
| LMVTCTVYAIKTRGV | 766 | Q14831 | |
| YMVTTVLLSVLVKRL | 416 | Q6UW02 | |
| LMLIITLVSVYCTRK | 666 | Q16820 | |
| RVKACYIMIGLTIIA | 106 | Q5T6X4 | |
| MLKKLLISYISIICV | 361 | Q7L1W4 | |
| VSYICILMTILKIQT | 216 | P0C626 | |
| IIIVCYTLMILRLKS | 241 | P41145 | |
| LRYTMILTSKIISLI | 136 | Q6IFG1 | |
| CLKVIVSLTVYTLFM | 431 | Q8WU17 | |
| MKLVTIFLLVTISLC | 1 | Q96PL1 | |
| SVIVVMTILLVVLYK | 141 | P49768 | |
| IMIILTSYLLILTTI | 211 | Q8NGL2 | |
| TLVVAVCTRKEYLTM | 651 | Q6ZNJ1 | |
| FLLCSTLLVIKMYVV | 16 | O14684 | |
| IMIILTSYLLILTTI | 211 | Q8NGL0 | |
| RTTLCLMFIVIYSSK | 6 | Q8IZF2 | |
| IVCYTMIILTLLKKS | 206 | Q9Y271 | |
| KTVLVLMCILTAYVL | 281 | Q8TCW9 | |
| VMLLLRVCKLIYTVM | 671 | Q8WYP3 | |
| RKTVLVLMCILTAYV | 271 | Q8NFJ6 | |
| KCIYTAVMVRRVILA | 331 | Q9NW08 | |
| SLALCVRILTTYLLM | 406 | Q4ZJI4 | |
| VTRVMYCVLSELEKT | 91 | Q13342 | |
| IRYIQLTEMKLSRCS | 201 | Q92623 | |
| LLVFIVILMVRYKVC | 546 | Q9ULH4 |